Correction: miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma.
Minna E, Romeo P, Dugo M, De Cecco L, Todoerti K, Pilotti S, Perrone F, Seregni E, Agnelli L, Neri A, Greco A, Borrello MG.
Minna E, et al. Among authors: neri a.
Oncotarget. 2018 Feb 23;9(15):12534. doi: 10.18632/oncotarget.24557. eCollection 2018 Feb 23.
Oncotarget. 2018.
PMID: 29552331
Free PMC article.